Evidence map›Paper›PMID 25231731›Full record

ArticleJournal of neuroscience research2015

Estrogen regulates energy metabolic pathway and upstream adenosine 5'-monophosphate-activated protein kinase and phosphatase enzyme expression in dorsal vagal complex metabolosensory neurons during glucostasis and hypoglycemia.

Pratistha Tamrakar, Baher A Ibrahim, Amit D Gujar, Karen P Briski

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Advances in the study of mitophagy in osteoarthritis.Journal of Zhejiang University. Science. B · 2024
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pratistha TamrakarDepartment of Basic Pharmaceutical Sciences, College of Pharmacy, The University of Louisiana at Monroe, Monroe, Louisiana.
Baher A Ibrahim
Amit D Gujar
Karen P Briski
University of Louisiana at Monroe · US

Funding

Hindbrain Glucoprivic Regulation of the HPG AxisR56DK085122 · NIDDK · UNIVERSITY OF LOUISIANA AT MONROE · PI BRISKI, KAREN P · 2010 to 2010
$213k
NIDDK NIH HHS DK085122NIDDK NIH HHS R56 DK085122
6 · The paper itself

Abstract

The ability of estrogen to shield the brain from the bioenergetic insult hypoglycemia is unclear. Estradiol (E) prevents hypoglycemic activation of the energy deficit sensor adenosine 5'-monophosphate-activated protein kinase (AMPK) in hindbrain metabolosensory A2 noradrenergic neurons. This study investigates the hypothesis that estrogen regulates A2 AMPK through control of fuel metabolism and/or upstream protein kinase/phosphatase enzyme expression. A2 cells were harvested by laser microdissection after insulin or vehicle (V) injection of E- or oil (O)-implanted ovariectomized female rats. Cell lysates were evaluated by immunoblot for glycolytic, tricarboxylic acid cycle, respiratory chain, and acetyl-CoA-malonyl-CoA pathway enzymes. A2 phosphofructokinase (PFKL), isocitrate dehydrogenase, pyruvate dehydrogenase, and ATP synthase subunit profiles were elevated in E/V vs. O/V; hypoglycemia augmented PFKL and α-ketoglutarate dehydrogenase expression in E only. Hypoglycemia increased A2 Ca(2+) /calmodulin-dependent protein kinase-β in O and reduced protein phosphatase in both groups. A2 phospho-AMPK levels were equivalent in O/V vs. E/V but elevated during hypoglycemia in O only. These results implicate E in compensatory upregulation of substrate catabolism and corresponding maintenance of energy stability of A2 metabolosensory neurons during hypoglycemia, outcomes that support the potential viability of molecular substrates for hormone action as targets for therapies alleviating hypoglycemic brain injury.

Indexed as

AMP-Activated Protein KinasesAnimalsAortic BodiesBlood GlucoseDisease Models, AnimalEstradiolEstrogen Receptor alphaEstrogen Receptor betaFemaleHypoglycemiaKetoglutarate Dehydrogenase ComplexLaser Capture MicrodissectionOvariectomyPhosphoric Monoester HydrolasesRatsRats, Sprague-DawleyAMP-Activated Protein KinasesBlood GlucoseEstradiolEstrogen Receptor alphaEstrogen Receptor betaKetoglutarate Dehydrogenase ComplexPhosphoric Monoester HydrolasesRNA, MessengerTyrosine 3-MonooxygenaseA2 noradrenergic neuronsacetyl-CoA carboxylasecalcium/calmodulin kinasefatty acid synthaseisocitrate dehydrogenaselaser-catapult microdissectionovariectomyphospho-AMPKphosphofructokinasePP2A

Identifiers

PMID25231731
PMCPMC4270942
OpenAlexW1586610468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.